December 13, 2011 article Open access Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma Clinical Cancer Research DOI: 10.1158/1078-0432.ccr-11-2479 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 653 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial 2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways 1 citations The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III–IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy—What Can Be Learned From Progression? 2023 Clinical Nuclear Medicine article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access 3 citations IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation 2023 Journal for ImmunoTherapy of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access 17 citations 3 results References 0